Header Logo

Connection

CANDELARIA GOMEZ-MANZANO to Oncolytic Viruses

Back to Details
This is a "connection" page, showing publications CANDELARIA GOMEZ-MANZANO has written about Oncolytic Viruses.
CANDELARIA GOMEZ-MANZANO
Connection Strength
4.798
Oncolytic Viruses
  1. Oncolytic adenoviruses and immunopeptidomics: a?convenient marriage. Mol Oncol. 2024 Apr; 18(4):781-784.
    View in: PubMed
    Score: 0.809
  2. Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas. Clin Cancer Res. 2019 11 15; 25(22):6801-6814.
    View in: PubMed
    Score: 0.588
  3. Oncolytic adenoviruses for the treatment of brain tumors. Curr Opin Mol Ther. 2010 Oct; 12(5):530-7.
    View in: PubMed
    Score: 0.317
  4. The emerging field of viroimmunotherapy for pediatric brain tumors. Neuro Oncol. 2024 Nov 04; 26(11):1981-1993.
    View in: PubMed
    Score: 0.211
  5. Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice. Mol Ther. 2024 Mar 06; 32(3):722-733.
    View in: PubMed
    Score: 0.200
  6. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Nat Med. 2023 Jun; 29(6):1370-1378.
    View in: PubMed
    Score: 0.190
  7. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. J Immunother Cancer. 2022 07; 10(7).
    View in: PubMed
    Score: 0.179
  8. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma. N Engl J Med. 2022 06 30; 386(26):2471-2481.
    View in: PubMed
    Score: 0.179
  9. Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory. Mol Cancer Ther. 2022 03 01; 21(3):471-480.
    View in: PubMed
    Score: 0.175
  10. An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus. Neuro Oncol. 2021 11 02; 23(11):1911-1921.
    View in: PubMed
    Score: 0.171
  11. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. J Neurosurg. 2022 Mar 01; 136(3):757-767.
    View in: PubMed
    Score: 0.169
  12. Hitchhiking to brain tumours: stem cell delivery of oncolytic viruses. Lancet Oncol. 2021 08; 22(8):1049-1051.
    View in: PubMed
    Score: 0.167
  13. Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy. J Immunother Cancer. 2021 04; 9(4).
    View in: PubMed
    Score: 0.164
  14. Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET. Clin Cancer Res. 2021 03 15; 27(6):1807-1820.
    View in: PubMed
    Score: 0.161
  15. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models. Nat Commun. 2019 05 28; 10(1):2235.
    View in: PubMed
    Score: 0.145
  16. Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018 05 10; 36(14):1419-1427.
    View in: PubMed
    Score: 0.132
  17. Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination. Cancer Res. 2017 07 15; 77(14):3894-3907.
    View in: PubMed
    Score: 0.126
  18. Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints. Curr Opin Virol. 2015 Aug; 13:33-9.
    View in: PubMed
    Score: 0.109
  19. C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. Oncogene. 2015 Oct 08; 34(41):5295-301.
    View in: PubMed
    Score: 0.107
  20. The oncolytic adenovirus ?24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity. J Bone Miner Res. 2014 Oct; 29(10):2287-96.
    View in: PubMed
    Score: 0.105
  21. Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PLoS One. 2014; 9(5):e97407.
    View in: PubMed
    Score: 0.102
  22. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol. 2011 May; 85(10):4720-9.
    View in: PubMed
    Score: 0.082
  23. Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas. Expert Rev Anticancer Ther. 2006 Nov; 6(11):1585-92.
    View in: PubMed
    Score: 0.060
  24. Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas. Viruses. 2024 Nov 14; 16(11).
    View in: PubMed
    Score: 0.053
  25. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models. Neuro Oncol. 2024 08 05; 26(8):1509-1525.
    View in: PubMed
    Score: 0.052
  26. Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens. PLoS One. 2016; 11(4):e0153814.
    View in: PubMed
    Score: 0.029
  27. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Cancer Res. 2007 Sep 01; 67(17):8255-63.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.